摘要
目的探究足月急性呼吸窘迫综合症新生儿临床治疗方法。方法随机选取我院收治90例足月急性呼吸窘迫综合症新生儿作为研究对象,随机分为实验组和对照组,每组患者45例。对照组患儿通过经鼻持续性正压通气治疗模式(NCPAP),实验组患儿通过气管内注入肺泡表面活性剂(固尔苏)治疗联合经鼻持续性正压通气治疗模式。结果对照组患儿的治疗有效率为91.1%,实验组患儿的治疗有效率为100.0%。结论通过气管内注入肺泡表面活性剂(固尔苏)联合经鼻持续性正压通气治疗模式治疗足月急性呼吸窘迫综合症能够取得良好的治疗效果。
Objective To investigate the clinical treatment of full-term infants with acute respiratory distress syndrome. Methods 90 cases of full- term acute respiratory distress syndrome in our hospital were randomly selected as the study subjects. They were randomly divided into the experimental group and the control group, with 45 patients in each g^oup. The children in control group by nasal continuous positive pressure ventilation treatment (NCPAP), the experimental group by intratracheal injection of pulmonary surfactant (Curosurf) treatment with nasal continuous positive airway pressure therapy mode. Results The effective rate of treatment in the control group was 91.1%, and the effective rate was 100.0% in the experimental group. Conclusion By intratracheal injection of pulmonary surfactant (Curosurf) combined with nasal continuous positive pressure ventilation can achieve good curative effect of treating syndrome model therapy for severe acute respiratory distress.
出处
《中国卫生标准管理》
2017年第20期76-77,共2页
China Health Standard Management
关键词
急性呼吸窘迫综合症
新生儿
治疗
acute respiratory distress syndrome
neonatal
treatment